Mankind Pharma IPO Review & Recommendations

Mankind Pharma IPO Peer Comparison

Mankind Pharma Limited peer comparison with similar listed entities. (Consolidated) (As on March 31, 2022)

Notes for listed peers:

1. Diluted EPS is sourced from the financial statements of the respective company for the year ended.
2. P/E Ratio has been computed based on the closing market price of equity shares on the National Stock Exchange of India Limited on March 24, 2023, divided by the Diluted EPS.
3. For listed peers, RoNW is computed as profit after tax for the year divided by closing net worth. Net worth has been considered as the total equity attributable to equity holders.
4. Net Asset Value ("NAV") is computed as the closing net worth divided by the equity shares outstanding as on March 31, 2022.
5. For Proctor & Gamble Health Limited, the latest financial statements are for the year ended June 30, 2022. Accordingly, revenue from operations, EPS, RoNW, and NAV pertain to the year ending June 30, 2022.
6. Torrent Pharmaceuticals Limited has announced a 1:1 bonus issue with an ex-bonus date on July 08, 2022. Accordingly, Diluted EPS for the year ended March 31, 2022, has been adjusted to reflect the bonus issue.